|
original article |
Date |
Title |
Authors All Authors |
1 |
[GO] |
2024―Feb―17 |
A cohort study comparing pharmacist activities during participation in general medical ward rounds: telehealth versus in-person during the COVID-19 pandemic |
Meng Yap, Gail Edwards, Harry Gibbs, Harvey Newnham, Nicole Hancock, Erica Y. Tong |
2 |
[GO] |
2023―Jun―28 |
Adherence to oral endocrine therapy in racial/ethnic minority patients with low socioeconomic status before and during the COVID-19 pandemic |
Sama Rahimi, Onyebuchi Ononogbu, Anjana Mohan, Daniel Moussa, Susan Abughosh, Meghana V. Trivedi |
3 |
[GO] |
2023―May―11 |
Pharmacist-driven antimicrobial stewardship interventions in patients with COVID-19: a scoping review |
Z. G. Nasr, W. Elamin, M. Basil, K. Eljaaly |
4 |
[GO] |
2023―Mar―27 |
Provision of drug and alcohol services amidst COVID-19 pandemic: a qualitative evaluation on the experiences of service providers |
Levi Richards-Jones, Priya Patel, Parbir Kaur Jagpal, Richard Lowrie, Karen Saunders, Sarah Burwood, et al. (+2) Sunil Shrestha, Vibhu Paudyal |
5 |
[GO] |
2023―Mar―24 |
Remdesivir for COVID-19 and acute kidney injury: disproportionality analysis of data from the U.S. Food and Drug Administration Adverse Event Reporting System |
Xiaotong Li, Liyuan Zhou, Martina Gaggl, Alan C. Kinlaw, Zhuoyue Gou, Yang Xu, et al. (+2) Jingkai Wei, Tiansheng Wang |
6 |
[GO] |
2022―Nov―11 |
Development, implementation and evaluation of a seven-day clinical pharmacy service in a tertiary referral teaching hospital during surge-2 of the COVID-19 pandemic |
C. Cheng, A. Walsh, S. Jones, S. Matthews, D. Weerasooriya, R. J. Fernandes, C. A. McKenzie |
7 |
[GO] |
2022―Oct―26 |
Community pharmacists’ expanding roles in supporting patients before and during COVID-19: An exploratory qualitative study |
Jennifer E. Isenor, Benoit Cossette, Andrea L. Murphy, Mylaine Breton, Maria Mathews, Lauren R. Moritz, et al. (+6) Richard Buote, Lisa McCarthy, Lisa Woodill, Bobbi Morrison, Line Guénette, Emily Gard Marshall |
8 |
[GO] |
2022―Oct―17 |
Sex differences among users of NSAIDs and opioids during COVID-19 Pandemic |
Roseanne Offiah, Laila Aboulatta, Payam Peymani, Basma Aloud, Kaarina Kowalec, Christine Leong, et al. (+4) Joseph Delaney, Jamie Falk, Silvia Alessi-Severini, Sherif Eltonsy |
9 |
[GO] |
2022―Jul―20 |
An observational, retrospective, comprehensive pharmacovigilance analysis of hydroxychloroquine-associated cardiovascular adverse events in patients with and without COVID-19 |
Min Luo, Bin Wu, Yuwen Li, Fengbo Wu |
10 |
[GO] |
2022―Jun―28 |
COVID-19 pandemic: the role of community-based pharmacy practice in health equity |
Youssef M. Roman |
11 |
[GO] |
2022―Apr―21 |
Trimetazidine and COVID-19-induced acute cardiac injury: a missed key |
Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Nermeen N. Welson, Gaber El-Saber Batiha |
12 |
[GO] |
2022―Jan―12 |
Self medication practices and its determinants in health care professionals during the coronavirus disease-2019 pandemic: cross-sectional study |
Ogochukwu Chinedum Okoye, Oluseyi Ademola Adejumo, Abimbola Olubukunola Opadeyi, Cynthia Roli Madubuko, Maureen Ntaji, Kenechukwu Chukwuemeka Okonkwo, et al. (+4) Imuetinyan Rashidat Edeki, Uchechukwu Oby Agboje, Oladimeji Emmanuel Alli, John Oghenevwirhe Ohaju-Obodo |
13 |
[GO] |
2021―Nov―10 |
Factors associated with Turkish pharmacists’ intention to receive COVID-19 vaccine: an observational study |
Betul Okuyan, Muhammed Yunus Bektay, Muhammed Yasir Demirci, Pınar Ay, Mesut Sancar |
14 |
[GO] |
2021―Oct―11 |
Using an online nominal group technique to determine key implementation factors for COVID-19 vaccination programmes in community pharmacies |
Dorothee Elsbeth Michel, Ayesha Iqbal, Laura Faehrmann, Ivana Tadić, Ema Paulino, Timothy F. Chen, Joanna C. Moullin |
15 |
[GO] |
2021―Oct―04 |
Using motivational interviewing techniques to inform decision-making for COVID-19 vaccination |
Monica Zolezzi, Bridget Paravattil, Taysier El-Gaili |
16 |
[GO] |
2021―Jul―30 |
Drug-induced liver injury associated with lopinavir-ritonavir in patients with COVID-19: a disproportionality analysis of U.S. food and drug administration adverse event reporting system (FAERS) data |
Huilin Tang, Liyuan Zhou, Xiaotong Li, Alan C. Kinlaw, Jeff Y. Yang, Andrew M. Moon, et al. (+2) Edward L. Barnes, Tiansheng Wang |
17 |
[GO] |
2021―Jul―03 |
Pharmacists’ involvement in COVID-19 vaccination across Europe: a situational analysis of current practice and policy |
Vibhu Paudyal, Daniela Fialová, Martin C. Henman, Ankie Hazen, Betul Okuyan, Monika Lutters, et al. (+6) Cathal Cadogan, Filipa Alves da Costa, Elena Galfrascoli, Yvonne Marina Pudritz, Silas Rydant, Jaime Acosta-Gómez |
18 |
[GO] |
2021―Jun―02 |
Guiding axes for drug safety management of pharmacovigilance centres during the COVID-19 era |
Renato Ferreira-da-Silva, Inês Ribeiro-Vaz, Manuela Morato, Jorge Junqueira Polónia |
19 |
[GO] |
2021―Apr―13 |
Burnout and the challenges facing pharmacists during COVID-19: results of a national survey |
Karlee Johnston, Claire L. O’Reilly, Brett Scholz, Ekavi N. Georgousopoulou, Imogen Mitchell |
20 |
[GO] |
2021―Mar―09 |
Sodium-glucose co-transporter 2 inhibitors in COVID-19: meeting at the crossroads between heart, diabetes and infectious diseases |
Theocharis Koufakis, Antonis N. Pavlidis, Symeon Metallidis, Kalliopi Kotsa |
21 |
[GO] |
2021―Jan―15 |
Community pharmacist’s professional adaptation amid Covid-19 emergency: a national survey on Italian pharmacists |
Corrado Giua, Giovanni Paoletti, Luigi Minerba, Giacomo Malipiero, Giulio Melone, Enrico Heffler, et al. (+2) Assunta Pistone, Enrico Keber |
22 |
[GO] |
2020―Sep―24 |
The therapeutic effects of traditional chinese medicine on COVID-19: a narrative review |
Can Wang, Shusen Sun, Xuansheng Ding |
23 |
[GO] |
2020―Aug―16 |
Managing medicines in the time of COVID-19: implications for community-dwelling people with dementia |
Heather E. Barry, Carmel M. Hughes |
24 |
[GO] |
2020―Jun―11 |
Provision of community pharmacy services during COVID-19 pandemic: a cross sectional study of community pharmacists’ experiences with preventative measures and sources of information |
Kreshnik Hoti, Arianit Jakupi, Dardan Hetemi, Denis Raka, Jeffery Hughes, Shane Desselle |
25 |
[GO] |
2020―May―30 |
The role of a Coronavirus disease 2019 pharmacist: an Australian perspective |
Jenny Nguy, Sarah A. Hitchen, Adam L. Hort, Cindy Huynh, Matthew D. M. Rawlins |
26 |
[GO] |
2020―May―14 |
Clinical characteristics and drug therapies in patients with the common-type coronavirus disease 2019 in Hunan, China |
Qiong Huang, Xuanyu Deng, Yongzhong Li, Xuexiong Sun, Qiong Chen, Mingxuan Xie, et al. (+6) Shao Liu, Hui Qu, Shouxian Liu, Ling Wang, Gefei He, Zhicheng Gong |
27 |
[GO] |
2020―May―07 |
Covid-19 and drug therapy, what we learned |
Alessio Provenzani, Piera Polidori |
28 |
[GO] |
2020―Apr―02 |
Providing pharmacy services at cabin hospitals at the coronavirus epicenter in China |
Long Meng, Feng Qiu, Shusen Sun |
29 |
[GO] |
2020―Mar―28 |
Providing pharmacy services during the coronavirus pandemic |
Shao Liu, Ping Luo, Mimi Tang, Qin Hu, Joseph P. Polidoro, Shusen Sun, Zhicheng Gong |